International Journal of Cancer · 2013 · 66 citations · 34 references
Life SciencesCancer BiologyCell BiologyCell SignalingMolecular Cell BiologySignal TransductionCancer Cell SignalingCancer Cell-cell CommunicationCell Signaling DisruptionCell Signaling NetworksSignal Transduction In CancerC-jun N-terminal Kinase SignalingCancer Signaling PathwaysExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingGap Junction Intercellular CommunicationGap Junctions In CancerMitogen-activated Protein Kinase CascadesMitogen-activated Protein Kinase Pathways
The use of preferentially replicating bacteria as oncolytic agents is one of the innovative approaches for the treatment of cancer. The capability of Salmonella to disperse within tumors and hence to delay tumor growth was augmented when combined with chemotherapy. This work is warranted to elucidate the underlying mechanism of antitumor effects by the combination therapy of Salmonella and cisplatin. The presence of functional gap junctions is highly relevant for the success of chemotherapy. Following Salmonella treatment, dose- and time-dependent upregulation of connexin 43 (Cx43) expressions were observed. Moreover, Salmonella significantly enhanced gap intercellular communication (GJIC), as revealed by the fluorescent dye scrape loading assay. To study the pathway underlying these Salmonella-induced effects, we found that Salmonella induced a significant increase in mitogen-activated protein kinases (MAPK) signaling pathways. The Salmonella-induced upregulation of Cx43 was prevented by treatment of cells with the phosphorylated p38 inhibitor, but not phosphorylated extracellular signal-regulated kinase (pERK) inhibitor or phosphorylated c-jun N terminal kinase (pJNK) inhibitor. Specific knockdown of Cx43 had an inhibitory effect on GJIC and resulted in a reduction of cell death after Salmonella and cisplatin treatment. Our results suggest that accumulation of Salmonella in tumor sites leads to increase Cx43 gap junction communication and enhances the combination of Salmonella and cisplatin therapeutic effects.
34
Tumor-targeted Salmonella as a novel anticancer vector.
John M. Pawelek, K. Brooks Low, David Bermudes · PubMed · 1997 · 527 citations
Medicine, Biotechnology, Oncology +12
Ming Zhao, Jack Geller, Huaiyu Ma et al. · Proceedings of the National Academy of Sciences · 2007 · 242 citations · Full text
Cancer Immunotherapy Based on Killing of <i>Salmonella</i> -Infected Tumor Cells
Francesca Avogadri, Chiara Martinoli, Liljana Petrovska et al. · Cancer Research · 2005 · 184 citations
Medicine, Immunology, Oncology +17